These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35220511)

  • 1. Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI.
    Yuen S; Monzawa S; Gose A; Yanai S; Yata Y; Matsumoto H; Ichinose Y; Tashiro T; Yamagami K
    Breast Cancer; 2022 Jul; 29(4):677-687. PubMed ID: 35220511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of contrast-enhanced digital mammography and contrast enhanced tomosynthesis--Comparison to contrast-enhanced breast MRI.
    Chou CP; Lewin JM; Chiang CL; Hung BH; Yang TL; Huang JS; Liao JB; Pan HB
    Eur J Radiol; 2015 Dec; 84(12):2501-8. PubMed ID: 26456307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital breast tomosynthesis and contrast-enhanced dual-energy digital mammography alone and in combination compared to 2D digital synthetized mammography and MR imaging in breast cancer detection and classification.
    Petrillo A; Fusco R; Vallone P; Filice S; Granata V; Petrosino T; Rosaria Rubulotta M; Setola SV; Mattace Raso M; Maio F; Raiano C; Siani C; Di Bonito M; Botti G
    Breast J; 2020 May; 26(5):860-872. PubMed ID: 31886607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric
    Leithner D; Helbich TH; Bernard-Davila B; Marino MA; Avendano D; Martinez DF; Jochelson MS; Kapetas P; Baltzer PAT; Haug A; Hacker M; Tanyildizi Y; Morris EA; Pinker K
    J Nucl Med; 2020 Jan; 61(1):20-25. PubMed ID: 31253745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
    Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
    BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Background Parenchymal Enhancement at Contrast-Enhanced Spectral Mammography (CESM) as a Breast Cancer Risk Factor.
    Sorin V; Yagil Y; Shalmon A; Gotlieb M; Faermann R; Halshtok-Neiman O; Sklair-Levy M
    Acad Radiol; 2020 Sep; 27(9):1234-1240. PubMed ID: 31812577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Background parenchymal enhancement on contrast-enhanced mammography: associations with breast density and patient's characteristics.
    Magni V; Cozzi A; Muscogiuri G; Benedek A; Rossini G; Fanizza M; Di Giulio G; Sardanelli F
    Radiol Med; 2024 Sep; 129(9):1303-1312. PubMed ID: 39060886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Architecture distortion score (ADS) in malignancy risk stratification of architecture distortion on contrast-enhanced digital mammography.
    Goh Y; Chan CW; Pillay P; Lee HS; Pan HB; Hung BH; Quek ST; Chou CP
    Eur Radiol; 2021 May; 31(5):2657-2666. PubMed ID: 33125555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of False-Positive Versus True-Positive Findings on Contrast-Enhanced Digital Mammography.
    Amir T; Hogan MP; Jacobs S; Sevilimedu V; Sung J; Jochelson MS
    AJR Am J Roentgenol; 2022 May; 218(5):797-808. PubMed ID: 34817195
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast-enhanced digital mammography and magnetic resonance imaging: reproducibility compared to pathologic anatomy.
    Liguori A; Depretto C; Ciniselli CM; Citterio A; Boffelli G; Verderio P; Scaperrotta GP
    Tumori; 2022 Dec; 108(6):563-571. PubMed ID: 34628982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep-learning model for background parenchymal enhancement classification in contrast-enhanced mammography.
    Ripaud E; Jailin C; Quintana GI; Milioni de Carvalho P; Sanchez de la Rosa R; Vancamberg L
    Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38657641
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of Clinical Factors and Degree of Early Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
    Wang S; Sun Y; You C; Jiang T; Yang M; Shen X; Qian M; Duan S; Lynn HS; Li R; Gu Y
    AJR Am J Roentgenol; 2023 Jul; 221(1):45-55. PubMed ID: 36695647
    [No Abstract]   [Full Text] [Related]  

  • 13. Contrast Enhanced Digital Mammography (CEDM) Helps to Safely Reduce Benign Breast Biopsies for Low to Moderately Suspicious Soft Tissue Lesions.
    Zuley ML; Bandos AI; Abrams GS; Ganott MA; Gizienski TA; Hakim CM; Kelly AE; Nair BE; Sumkin JH; Waheed U; Gur D
    Acad Radiol; 2020 Jul; 27(7):969-976. PubMed ID: 31495761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadoteridol-enhanced MRI of the breast: can contrast agent injection rate impact background parenchymal enhancement?
    Marzocca F; Moffa G; Landi VN; Panzironi G; Kirchin MA; Pediconi F; Galati F
    Acta Radiol; 2022 Sep; 63(9):1173-1179. PubMed ID: 34323589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study.
    Watt GP; Sung J; Morris EA; Buys SS; Bradbury AR; Brooks JD; Conant EF; Weinstein SP; Kontos D; Woods M; Colonna SV; Liang X; Stein MA; Pike MC; Bernstein JL
    Breast Cancer Res; 2020 Dec; 22(1):138. PubMed ID: 33287857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
    Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
    AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
    Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
    Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the applicability of BI-RADS® MRI for the interpretation of contrast-enhanced digital mammography.
    Travieso-Aja MM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Luzardo OP
    Radiologia (Engl Ed); 2019; 61(6):477-488. PubMed ID: 31262509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study.
    Yu L; Wang Y; Xing D; Gong P; Chen Q; Lv Y
    Medicine (Baltimore); 2020 Dec; 99(52):e23857. PubMed ID: 33350778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.
    Arasu VA; Miglioretti DL; Sprague BL; Alsheik NH; Buist DSM; Henderson LM; Herschorn SD; Lee JM; Onega T; Rauscher GH; Wernli KJ; Lehman CD; Kerlikowske K
    J Clin Oncol; 2019 Apr; 37(12):954-963. PubMed ID: 30625040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.